These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1053 related articles for article (PubMed ID: 29942093)

  • 1. A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments.
    Barry KC; Hsu J; Broz ML; Cueto FJ; Binnewies M; Combes AJ; Nelson AE; Loo K; Kumar R; Rosenblum MD; Alvarado MD; Wolf DM; Bogunovic D; Bhardwaj N; Daud AI; Ha PK; Ryan WR; Pollack JL; Samad B; Asthana S; Chan V; Krummel MF
    Nat Med; 2018 Aug; 24(8):1178-1191. PubMed ID: 29942093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control.
    Böttcher JP; Bonavita E; Chakravarty P; Blees H; Cabeza-Cabrerizo M; Sammicheli S; Rogers NC; Sahai E; Zelenay S; Reis e Sousa C
    Cell; 2018 Feb; 172(5):1022-1037.e14. PubMed ID: 29429633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Natural Killer-Dendritic Cell Immune Axis in Anti-Cancer Immunity and Immunotherapy.
    Peterson EE; Barry KC
    Front Immunol; 2020; 11():621254. PubMed ID: 33613552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
    Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer.
    Bödder J; Zahan T; van Slooten R; Schreibelt G; de Vries IJM; Flórez-Grau G
    Front Immunol; 2020; 11():631713. PubMed ID: 33679726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of innate immunity in the tumor microenvironment.
    Gonzalez-Gugel E; Saxena M; Bhardwaj N
    Cancer Immunol Immunother; 2016 Oct; 65(10):1261-8. PubMed ID: 27344341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.
    Xu X; Li J; Zou J; Feng X; Zhang C; Zheng R; Duanmu W; Saha-Mandal A; Ming Z; Wang E
    JAMA Netw Open; 2019 Sep; 2(9):e199292. PubMed ID: 31483464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies.
    Mullins SR; Vasilakos JP; Deschler K; Grigsby I; Gillis P; John J; Elder MJ; Swales J; Timosenko E; Cooper Z; Dovedi SJ; Leishman AJ; Luheshi N; Elvecrog J; Tilahun A; Goodwin R; Herbst R; Tomai MA; Wilkinson RW
    J Immunother Cancer; 2019 Sep; 7(1):244. PubMed ID: 31511088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
    Gaggero S; Witt K; Carlsten M; Mitra S
    Front Immunol; 2020; 11():621225. PubMed ID: 33584718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD56
    Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
    Front Immunol; 2019; 10():14. PubMed ID: 30761123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK Cell Anti-Tumor Surveillance in a Myeloid Cell-Shaped Environment.
    Russo E; Laffranchi M; Tomaipitinca L; Del Prete A; Santoni A; Sozzani S; Bernardini G
    Front Immunol; 2021; 12():787116. PubMed ID: 34975880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy.
    Zhang C; Liu Y
    Front Immunol; 2020; 11():1295. PubMed ID: 32714324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor Microenvironment.
    Palicelli A; Croci S; Bisagni A; Zanetti E; De Biase D; Melli B; Sanguedolce F; Ragazzi M; Zanelli M; Chaux A; Cañete-Portillo S; Bonasoni MP; Soriano A; Ascani S; Zizzo M; Castro Ruiz C; De Leo A; Giordano G; Landriscina M; Carrieri G; Cormio L; Berney DM; Gandhi J; Copelli V; Bernardelli G; Santandrea G; Bonacini M
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and Manipulation of the Crosstalk Between Dendritic and Natural Killer Cells Within the Tumor Microenvironment.
    Jacobs B; Gebel V; Heger L; Grèze V; Schild H; Dudziak D; Ullrich E
    Front Immunol; 2021; 12():670540. PubMed ID: 34054844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment.
    Lam KC; Araya RE; Huang A; Chen Q; Di Modica M; Rodrigues RR; Lopès A; Johnson SB; Schwarz B; Bohrnsen E; Cogdill AP; Bosio CM; Wargo JA; Lee MP; Goldszmid RS
    Cell; 2021 Oct; 184(21):5338-5356.e21. PubMed ID: 34624222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy.
    Mortara L; Balza E; Bruno A; Poggi A; Orecchia P; Carnemolla B
    Front Immunol; 2018; 9():2905. PubMed ID: 30619269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of NK cells and dendritic cells in the tumor environment: how to enforce NK cell & DC action under immunosuppressive conditions?
    Jacobs B; Ullrich E
    Curr Med Chem; 2012; 19(12):1771-9. PubMed ID: 22414086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cells.
    Wong JL; Mailliard RB; Moschos SJ; Edington H; Lotze MT; Kirkwood JM; Kalinski P
    J Immunother; 2011 Apr; 34(3):270-8. PubMed ID: 21389871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pan-cancer single-cell panorama of human natural killer cells.
    Tang F; Li J; Qi L; Liu D; Bo Y; Qin S; Miao Y; Yu K; Hou W; Li J; Peng J; Tian Z; Zhu L; Peng H; Wang D; Zhang Z
    Cell; 2023 Sep; 186(19):4235-4251.e20. PubMed ID: 37607536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.